[{"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-001", "question": "A 45-year-old woman presents with progressive bilateral hearing loss, facial numbness, and ataxia. MRI reveals bilateral enhancing cerebellopontine angle masses with significant brainstem compression. Genetic testing confirms a missense mutation in the SMARCB1 gene. After maximal safe resection of the larger tumor, which management strategy offers the best long-term tumor control while preserving neurological function?", "options": ["Treatment with a selective histone deacetylase 6 (HDAC6) inhibitor", "Initiation of mTOR complex 1/2 dual inhibitor therapy", "Conformal radiotherapy targeting both lesions with dose painting", "Observation with serial MRI and consideration of bevacizumab for symptom control", "Prophylactic ventriculoperitoneal shunting followed by chemotherapy with carboplatin/vincristine"], "answer": "A", "answer_index": 0, "explanation": "The clinical scenario describes schwannomatosis due to SMARCB1 mutation. HDAC6 inhibitors have shown specific efficacy in preclinical models of SMARCB1-deficient tumors by restoring protein homeostasis and inducing apoptosis, unlike broader epigenetic modifiers. mTOR inhibitors are more relevant for NF2-related schwannomas, while radiotherapy is contraindicated in schwannomatosis due to malignant transformation risk. Bevacizumab has limited efficacy in SMARCB1-mutant tumors compared to NF2-mutant schwannomas.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: SMARCB1 mutation, bilateral CPA masses, brainstem compression, post-residual tumor. The item asks for best long-term control preserving function. The keyed answer (A, HDAC6 inhibitor) is based on preclinical data, not established clinical standard of care. The most defensible best answer is C (conformal radiotherapy), as it is a standard, effective local control modality for symptomatic, unresectable vestibular schwannomas, even in schwannomatosis, despite a debated transformation risk. Observation (D) is inappropriate given significant brainstem compression. mTOR inhibitors (B) and chemotherapy (E) are not standard. Main medical issue: Answer A represents experimental therapy misrepresented as best. Minimal fix: Change key to C and adjust rationale to reflect current standard radiotherapy consideration for progressive, symptomatic tumors.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: SMARCB1 mutation, bilateral CPA masses, brainstem compression, post-residual tumor. The item asks for best long-term control preserving function. The keyed answer (A, HDAC6 inhibitor) is based on preclinical data, not established clinical standard of care. The most defensible best answer is C (conformal radiotherapy), as it is a standard, effective local control modality for symptomatic, unresectable vestibular schwannomas, even in schwannomatosis, despite a debated transformation risk. Observation (D) is inappropriate given significant brainstem compression. mTOR inhibitors (B) and chemotherapy (E) are not standard. Main medical issue: Answer A represents experimental therapy misrepresented as best. Minimal fix: Change key to C and adjust rationale to reflect current standard radiotherapy consideration for progressive, symptomatic tumors.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-002", "question": "A 68-year-old man with locally advanced pancreatic cancer involving the celiac axis undergoes stereotactic body radiotherapy (SBRT) to 40 Gy in 5 fractions. Three months later, he develops severe epigastric pain and hematemesis. Endoscopy reveals a deeply ulcerated lesion in the gastric antrum with visible vessel. Biopsy shows radiation-induced changes without malignancy. Which interventional approach is most likely to achieve durable hemostasis while minimizing the risk of gastric perforation?", "options": ["Over-the-scope clip placement with concomitant fibrin glue injection", "Hybrid argon plasma coagulation combined with topical hemostatic powder", "Selective angiography with coil embolization of the gastroduodenal artery", "Endoscopic ultrasound-guided cyanoacrylate injection into the peri-ulcer bed", "Temporary covered esophageal stent placement with nasojejunal feeding tube"], "answer": "D", "answer_index": 3, "explanation": "After high-dose SBRT, conventional endoscopic therapies often fail due to compromised tissue healing. EUS-guided cyanoacrylate injection directly targets the feeding vessel deep within the ulcer bed, creating a permanent seal without the tissue disruption caused by thermal modalities. Over-the-scope clips may not hold in friable irradiated tissue, while angiographic embolization risks non-target ischemia. Topical agents provide only temporary control in this high-flow scenario.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: severe bleeding from a radiation-induced gastric ulcer with visible vessel after high-dose SBRT, requiring durable hemostasis while minimizing perforation risk. Main logical issue: The keyed answer (D, EUS-guided cyanoacrylate injection) is not the standard of care for a non-variceal, non-malignant bleeding ulcer with a visible vessel. The universally accepted first-line intervention for a high-risk peptic ulcer with a visible vessel is endoscopic hemostasis, typically with dual therapy (e.g., epinephrine injection plus thermal coagulation or mechanical clip). Cyanoacrylate glue is reserved for gastric varices. Therefore, a unique best answer exists, but the provided key is incorrect. Main medical accuracy issue: Recommending an unproven, off-label, and potentially hazardous therapy (cyanoacrylate injection into a non-variceal ulcer bed) over established first-line endoscopic treatments is a major inaccuracy. Minimal fix: Change the key to A or B, representing standard endoscopic hemostatic techniques, and adjust the rationale accordingly.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1235)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-003", "question": "A 52-year-old man undergoes right pneumonectomy for T3N2M0 non-small cell lung cancer. On postoperative day 4, he develops acute respiratory distress. Chest tube output abruptly decreases, and the mediastinum shifts toward the left on radiograph. Bronchoscopy reveals a 1.5 cm dehiscence of the bronchial stump without frank disruption. What is the most appropriate immediate management?", "options": ["Emergency rethoracotomy with direct stump revision", "Placement of a second chest tube to water seal", "Immediate bedside reopening of the incision with antibiotic irrigation", "Flexible bronchoscopic placement of an endobronchial valve in the right main bronchus", "Urgent veno-venous ECMO cannulation followed by operative repair"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes a post-pneumonectomy bronchopleural fistula with impending tension physiology. Immediate bedside reopening allows mediastinal decompression and converts the situation to an open pleural cavity, preventing fatal tension. This is followed by formal operative repair after stabilization. Endobronchial valves are ineffective for large proximal dehiscences. Re-thoracotomy without decompression risks cardiovascular collapse. ECMO is reserved for refractory respiratory failure after initial stabilization.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Post-pneumonectomy, acute respiratory distress, decreased chest tube output, mediastinal shift toward the contralateral side (left), and bronchoscopic finding of a 1.5 cm bronchial stump dehiscence. This describes a post-pneumonectomy bronchopleural fistula (BPF) with tension physiology, a surgical emergency. The standard, immediate life-saving intervention is to relieve the tension by opening the wound at the bedside (creating an 'open window thoracostomy'), which is option C. However, the provided rationale correctly describes this, but the keyed answer is incorrectly listed as C, which matches the correct action. There is a mismatch between the listed key and the described correct action in the audit. The key is correct, but the audit logic flagged a miskey due to internal evaluation. The unique best answer is C. Main logical issue: The item is valid, but the audit process incorrectly flagged a key mismatch. Minimal fix: Ensure the key in the data structure matches the letter of the correct option (C).\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":  \t\n    \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Post-pneumonectomy, acute respiratory distress, decreased chest tube output, mediastinal shift toward the contralateral side (left), and bronchoscopic finding of a 1.5 cm bronchial stump dehiscence. This describes a post-pneumonectomy bronchopleural fistula (BPF) with tension physiology, a surgical emergency. The standard, immediate life-saving intervention is to relieve the tension by opening the wound at the bedside (creating an 'open window thoracostomy'), which is option C. However, the provided rationale correctly describes this, but the keyed answer is incorrectly listed as C, which matches the correct action. There is a mismatch between the listed key and the described correct action in the audit. The key is correct, but the audit logic flagged a miskey due to internal evaluation. The unique best answer is C. Main logical issue: The item is valid, but the audit process incorrectly flagged a key mismatch. Minimal fix: Ensure the key in the data structure matches the letter of the correct option (C).", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-004", "question": "A 74-year-old man with a history of abdominal aortic aneurysm repair presents with acute onset of painful blue discoloration of his toes despite palpable pedal pulses. Laboratory studies show elevated creatinine kinase and acute kidney injury. Angiography demonstrates patent bypass graft but diffuse microvascular occlusion in both feet. What is the most appropriate emergent intervention?", "options": ["Immediate bilateral sympathectomy", "Systemic heparinization followed by catheter-directed thrombolysis", "High-dose corticosteroid pulse therapy", "Emergent surgical embolectomy of the tibial vessels", "Plasma exchange with albumin replacement"], "answer": "E", "answer_index": 4, "explanation": "The presentation is consistent with cholesterol embolization syndrome following aortic manipulation. Plasma exchange removes inflammatory mediators and cholesterol-laden microemboli, improving microcirculatory flow. Thrombolysis is ineffective for cholesterol crystals and increases hemorrhage risk. Sympathectomy helps vasospasm but doesn't address the embolic load. Corticosteroids may modestly reduce inflammation but don't remove emboli. Surgical embolectomy cannot access distal microvasculature.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: acute painful blue toes with palpable pulses after aortic aneurysm repair, elevated CK, AKI, angiography showing patent graft but diffuse microvascular occlusion—classic for cholesterol embolization syndrome (atheroembolism). The most appropriate emergent intervention for this condition is supportive care and risk factor management; no emergent intervention is definitively proven. Plasma exchange (keyed answer) is not a standard, evidence-based emergent intervention. Systemic heparinization (option B) is often considered to prevent thrombosis in the setting of immobility and ischemia, and is a more common initial step, making it a defensible best answer. The item is miskeyed. Main medical accuracy issue: presenting plasma exchange as the most appropriate emergent intervention is not aligned with mainstream guidelines. Minimal fix: Change the key to B (Systemic heparinization) and adjust the rationale to reflect that anticoagulation is a typical initial supportive measure, while noting the lack of high-quality evidence for emergent specific therapies.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: acute painful blue toes with palpable pulses after aortic aneurysm repair, elevated CK, AKI, angiography showing patent graft but diffuse microvascular occlusion—classic for cholesterol embolization syndrome (atheroembolism). The most appropriate emergent intervention for this condition is supportive care and risk factor management; no emergent intervention is definitively proven. Plasma exchange (keyed answer) is not a standard, evidence-based emergent intervention. Systemic heparinization (option B) is often considered to prevent thrombosis in the setting of immobility and ischemia, and is a more common initial step, making it a defensible best answer. The item is miskeyed. Main medical accuracy issue: presenting plasma exchange as the most appropriate emergent intervention is not aligned with mainstream guidelines. Minimal fix: Change the key to B (Systemic heparinization) and adjust the rationale to reflect that anticoagulation is a typical initial supportive measure, while noting the lack of high-quality evidence for emergent specific therapies.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-005", "question": "A 38-year-old woman with Crohn's disease maintained on vedolizumab presents with recurrent episodes of postprandial abdominal pain and 15-pound weight loss. CT enterography shows patent superior mesenteric artery and vein. Gastric emptying study is normal. Diagnostic laparoscopy reveals no adhesions. Which test will most likely establish the diagnosis?", "options": ["Mesenteric Doppler ultrasound with a standardized meal challenge", "Lactulose hydrogen breath test for small intestinal bacterial overgrowth", "Serum tryptase level during symptomatic episode", "Selective mesenteric angiography with vasodilator challenge", "Video capsule endoscopy with patency capsule confirmation"], "answer": "A", "answer_index": 0, "explanation": "This presentation suggests chronic mesenteric ischemia despite patent gross vasculature, possibly from vedolizumab-associated microvascular dysfunction. Provocative mesenteric Doppler can demonstrate reduced postprandial flow reserve. While bacterial overgrowth is common in Crohn's, it doesn't explain the postprandial timing. Angiography shows macrovascular disease already ruled out. Capsule endoscopy may show mucosal changes but doesn't assess flow dynamics. Tryptase would indicate mast cell disorder, which is less likely.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: U (Underspecified). Verdict: Not uniquely determinable. The vignette describes recurrent postprandial pain and weight loss in a patient with Crohn's on vedolizumab, with normal CT angiography, gastric emptying, and laparoscopy. The keyed answer (A, mesenteric Doppler) is proposed to diagnose 'microvascular dysfunction,' a condition not established in standard gastroenterology for Crohn's or vedolizumab. The stem lacks critical details to rule in this novel pathophysiology or to rule out more common etiologies like small intestinal bacterial overgrowth (SIBO, option B) or Crohn's-related strictures/complications not seen on laparoscopy. The logic requires an unstated assumption that microvascular ischemia is the primary cause. Main medical issue: The core premise (vedolizumab-associated microvascular ischemia) is not a recognized entity, making the keyed answer unsupported. Minimal fix: Specify findings that specifically suggest mesenteric ischemia (e.g., postprandial pain relief with nitrates, elevated lactate) and explicitly rule out SIBO with prior testing to justify A over B.\",\n  \"logical_false_reason\": \"U\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified). Verdict: Not uniquely determinable. The vignette describes recurrent postprandial pain and weight loss in a patient with Crohn's on vedolizumab, with normal CT angiography, gastric emptying, and laparoscopy. The keyed answer (A, mesenteric Doppler) is proposed to diagnose 'microvascular dysfunction,' a condition not established in standard gastroenterology for Crohn's or vedolizumab. The stem lacks critical details to rule in this novel pathophysiology or to rule out more common etiologies like small intestinal bacterial overgrowth (SIBO, option B) or Crohn's-related strictures/complications not seen on laparoscopy. The logic requires an unstated assumption that microvascular ischemia is the primary cause. Main medical issue: The core premise (vedolizumab-associated microvascular ischemia) is not a recognized entity, making the keyed answer unsupported. Minimal fix: Specify findings that specifically suggest mesenteric ischemia (e.g., postprandial pain relief with nitrates, elevated lactate) and explicitly rule out SIBO with prior testing to justify A over B.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-006", "question": "A 65-year-old man presents with acute severe hematochezia. Colonoscopy reveals active bleeding from a non-ulcerated lesion in the ascending colon with a visible vessel. Biopsy shows dilated submucosal veins without evidence of vasculitis or neoplasia. CT angiography shows no arterial malformation. What is the most appropriate endoscopic therapy?", "options": ["Heater probe coagulation with high power settings", "Endoscopic band ligation of the lesion", "Injection of N-butyl-2-cyanoacrylate glue", "Placement of through-the-scope clips in a circumferential pattern", "Argon plasma coagulation with extended application time"], "answer": "B", "answer_index": 1, "explanation": "The findings are characteristic of Dieulafoy's lesion of the colon, which involves a abnormally large submucosal artery. Endoscopic band ligation is superior to thermal or clipping methods as it mechanically secures the vessel with low recurrence rates. Cyanoacrylate injection risks embolization in this location. Thermal methods may not adequately coagulate the large caliber vessel. Clips may not achieve full-thickness compression needed for this lesion type.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: acute severe hematochezia, ascending colon lesion, visible vessel, biopsy shows dilated submucosal veins without vasculitis/neoplasia, CT angiography shows no arterial malformation. The description is most consistent with a colonic Dieulafoy lesion, which is an abnormally large, tortuous submucosal ARTERY, not a vein. The keyed answer (B, band ligation) is a valid treatment for Dieulafoy lesions, but the rationale incorrectly describes the histology. The primary logical issue is miskeying: option C (cyanoacrylate glue injection) is a widely accepted, guideline-recommended first-line therapy for Dieulafoy lesions, often considered superior to band ligation for non-variceal lesions, making it a defensible best answer and creating a 'K' (Miskeyed) scenario. Medical accuracy is problematic (score 2) due to the fundamental histologic error (artery vs. vein) in the explanation. Minimal fix: Correct the rationale to state 'abnormally large submucosal artery' and consider updating the key to C if following modern endoscopic hemostasis guidelines.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1239)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-007", "question": "A 55-year-old man with autosomal dominant polycystic kidney disease (ADPKD) and estimated glomerular filtration rate of 35 mL/min/1.73m² presents with acute left flank pain. CT shows a 8cm left renal cyst with hyperdense material and a fluid-debris level. Urinalysis shows 25-50 white blood cells but no bacteria. He is afebrile with normal blood pressure. What is the most appropriate management?", "options": ["Immediate initiation of ciprofloxacin", "Percutaneous drainage with cyst fluid culture", "CT-guided aspiration for cytology", "Hospital admission for intravenous ampicillin-sulbactam", "Analgesia and follow-up imaging in 4-6 weeks"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests an infected renal cyst in ADPKD, which requires drainage for both diagnosis and therapy. Cyst infections often present with minimal systemic signs in ADPKD patients. Antibiotics alone penetrate cysts poorly. Percutaneous drainage confirms the diagnosis, provides targeted therapy, and prevents sepsis. Aspiration for cytology would miss infection. Observation risks abscess formation. IV antibiotics without drainage are unlikely to eradicate the infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: ADPKD with acute flank pain, large renal cyst with hyperdense material/fluid-debris level, sterile pyuria, and afebrile status point to an infected cyst. The lack of fever and systemic signs is typical in ADPKD. The best answer is percutaneous drainage with culture (B), as antibiotics alone poorly penetrate cysts, and drainage is both diagnostic and therapeutic. The keyed answer is consistent with standard management. Alternatives are inferior: antibiotics alone (A, D) are insufficient; cytology (C) misses infection; observation (E) risks abscess. No logical contradictions or missing critical details exist. Minimal fix: None required; the item is already clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: ADPKD with acute flank pain, large renal cyst with hyperdense material/fluid-debris level, sterile pyuria, and afebrile status point to an infected cyst. The lack of fever and systemic signs is typical in ADPKD. The best answer is percutaneous drainage with culture (B), as antibiotics alone poorly penetrate cysts, and drainage is both diagnostic and therapeutic. The keyed answer is consistent with standard management. Alternatives are inferior: antibiotics alone (A, D) are insufficient; cytology (C) misses infection; observation (E) risks abscess. No logical contradictions or missing critical details exist. Minimal fix: None required; the item is already clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-008", "question": "A 28-year-old woman develops recurrent sinopulmonary infections and bronchiectasis. Workup reveals absent IgA, markedly reduced IgG and IgM, and absent B cells on flow cytometry. Genetic testing identifies a mutation in the λ5 surrogate light chain gene. Which specific immunological abnormality explains her infection pattern?", "options": ["Failure of heavy chain rearrangement in pre-B cells", "Defective VDJ recombination due to RAG deficiency", "Absence of the pre-B cell receptor complex signaling", "Mutation in the BLNK adapter protein preventing PLCγ activation", "Loss of BTK enzyme function disrupting B cell maturation"], "answer": "C", "answer_index": 2, "explanation": "The λ5 gene encodes part of the surrogate light chain critical for pre-B cell receptor formation. Without functional pre-BCR signaling, B cells fail to proliferate and mature at the pre-B cell stage, causing the arrested development seen here. This is distinct from Bruton's tyrosine kinase deficiency (which affects later signaling) or RAG deficiencies (which impair initial recombination). The specific λ5 mutation explains the profound B cell deficiency and hypogammaglobulinemia.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: recurrent sinopulmonary infections, bronchiectasis, absent IgA, markedly reduced IgG/IgM, absent B cells, and a specific mutation in the λ5 surrogate light chain gene. The question asks for the specific immunological abnormality explained by this mutation. The λ5 protein is a critical component of the surrogate light chain, which pairs with the μ heavy chain to form the pre-B cell receptor (pre-BCR). A mutation in λ5 directly causes absence of the pre-BCR complex and its signaling, halting B cell development at the pre-B cell stage, consistent with the lab findings. Option C correctly identifies this. Alternatives are incorrect: A (heavy chain rearrangement) occurs earlier and is intact here; B (RAG deficiency) affects earlier VDJ recombination; D (BLNK/PLCγ) and E (BTK) affect signaling downstream of the pre-BCR. No contradictions or missing details. Medical accuracy is sound. Minimal fix: None required; item is clear and accurate.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1134)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-009", "question": "A 42-year-old immigrant from rural Venezuela presents with progressive dyspnea and hemoptysis. Echocardiography shows severe pulmonary hypertension with right ventricular hypertrophy. Serology is positive for Strongyloides stercoralis antibodies. CT chest reveals diffuse ground-glass opacities with bronchial wall thickening. What is the most appropriate initial treatment?", "options": ["Ivermectin alone", "Ivermectin plus prednisone", "Albendazole plus diethylcarbamazine", "Praziquantel followed by ivermectin", "Thiabendazole with gradual pulmonary vasodilator therapy"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests Strongyloides hyperinfection syndrome with associated pulmonary involvement. Treatment requires both anthelminthic therapy (ivermectin) and corticosteroids to prevent lethal inflammatory response from dying larvae (paradoxical worsening). Using ivermectin alone risks fatal inflammatory reaction. Albendazole is less effective for Strongyloides. Praziquantel treats schistosomiasis, not strongyloidiasis. Vasodilators don't address the underlying parasitic infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: immigrant from endemic area (Venezuela), progressive dyspnea/hemoptysis, severe pulmonary hypertension, positive Strongyloides serology, and CT showing diffuse ground-glass opacities with bronchial wall thickening. These findings strongly suggest Strongyloides hyperinfection syndrome with pulmonary involvement, where initial treatment requires both anthelminthic therapy (ivermectin) and corticosteroids to mitigate the inflammatory response from dying larvae. The logic is sound: ivermectin alone (A) risks fatal inflammatory reaction; albendazole-based regimens (C, E) are less effective or inappropriate; praziquantel (D) is for schistosomiasis. No contradictions or missing critical details. Medical accuracy is consistent with guidelines for hyperinfection. Minimal fix: None required; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: immigrant from endemic area (Venezuela), progressive dyspnea/hemoptysis, severe pulmonary hypertension, positive Strongyloides serology, and CT showing diffuse ground-glass opacities with bronchial wall thickening. These findings strongly suggest Strongyloides hyperinfection syndrome with pulmonary involvement, where initial treatment requires both anthelminthic therapy (ivermectin) and corticosteroids to mitigate the inflammatory response from dying larvae. The logic is sound: ivermectin alone (A) risks fatal inflammatory reaction; albendazole-based regimens (C, E) are less effective or inappropriate; praziquantel (D) is for schistosomiasis. No contradictions or missing critical details. Medical accuracy is consistent with guidelines for hyperinfection. Minimal fix: None required; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-010", "question": "A 65-year-old liver transplant recipient on tacrolimus, mycophenolate, and prednisone presents with altered mental status and focal neurological deficits. MRI shows multiple ring-enhancing lesions with eccentric target sign. CSF PCR is positive for JC virus. What is the most appropriate management?", "options": ["Reduce immunosuppression and initiate intravenous cidofovir", "Immediate exchange transfusion to reduce tacrolimus levels", "Switch from mycophenolate to everolimus and add mirtazapine", "Administer brincidofovir and intravenous immunoglobuli", "Empiric treatment with pyrimethamine/sulfadiazine for toxoplasmosis"], "answer": "C", "answer_index": 2, "explanation": "This is progressive multifocal leukoencephalopathy (PML) in an immunocompromised host. The cornerstone is reducing immunosuppression, specifically switching from mycophenolate (which strongly inhibits T-cell function) to everolimus (which has anti-neoplastic properties and may slow PML progression). Mirtazapine has shown potential benefit by blocking 5-HT2A receptors that JC virus uses for entry. Cidofovir is ineffective against JC virus. Exchange transfusion is not indicated. Antitoxoplasma therapy would be incorrect with positive JC virus PCR.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Immunosuppressed transplant recipient, MRI ring-enhancing lesions with target sign, CSF JC virus PCR positive, confirming PML. Main logical issue: The keyed answer (C) is not the single best answer. The cornerstone of PML management in iatrogenic immunosuppression is reduction of immunosuppression. While switching from mycophenolate to everolimus is a plausible immunosuppression reduction strategy, the most direct and evidence-based initial step is simply to reduce the overall immunosuppressive burden. Option A (reduce immunosuppression) is a more fundamental and universally accepted first step than the specific drug switch in C. The addition of mirtazapine is of unproven benefit. Main medical accuracy issue: The item correctly identifies PML and rules out other options, but over-specifies a non-standard first-line regimen as the 'most appropriate' management. Minimal fix: Change the key to A, or rephrase the stem to ask for a 'novel adjunctive therapy' rather than 'most appropriate management.'\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1190)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-011", "question": "A 34-year-old woman presents with progressive visual field loss. MRI reveals a large suprasellar mass extending into the third ventricle with homogeneous enhancement. Endoscopic biopsy shows a mixed glial and neuronal tumor with neurocytic rosettes and perivascular pseudorosettes. Genetic analysis demonstrates BRAF V600E mutation. What is the most appropriate surgical strategy?", "options": ["Attempt gross total resection via endoscopic endonasal approach", "Subtotal resection followed by targeted BRAF inhibitor therapy", "Open craniotomy with interhemispheric transcallosal approach", "Lateral ventricle endoscopic resection with third ventriculostomy", "Stereotactic biopsy followed by conformal radiotherapy"], "answer": "B", "answer_index": 1, "explanation": "The histology describes a papillary glioneuronal tumor, a low-grade neoplasm with favorable prognosis. When BRAF V600E mutation is present, targeted therapy with BRAF inhibitors can achieve significant tumor reduction with less surgical morbidity compared to aggressive resection for this deeply located tumor. Gross total resection risks hypothalamic injury given the suprasellar location. Radiotherapy is reserved for progressive disease after medical therapy. The transcallosal approach would provide inadequate exposure for this primarily suprasellar lesion.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (B) suggests subtotal resection followed by targeted therapy, but the stem's description of a 'large suprasellar mass extending into the third ventricle' and the histology (papillary glioneuronal tumor) strongly indicates a need for maximal safe resection as the primary surgical goal, with adjuvant therapy considered postoperatively. Option A (gross total resection via endoscopic endonasal) is a defensible and often preferred first-line surgical strategy for accessible suprasellar lesions to obtain tissue diagnosis and debulk, making it a strong contender. The key's rationale prematurely prioritizes medical therapy over surgical cytoreduction, which is not the standard initial approach for a symptomatic, resectable low-grade glioma. The item is medically accurate but logically miskeyed. Minimal fix: Change the key to A or revise the stem to specify the tumor is unresectable or the patient is not a surgical candidate.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1111)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-012", "question": "A 72-year-old man with metastatic castration-resistant prostate cancer to bones undergoes palliative radiotherapy to a symptomatic lumbar spine metastasis (8 Gy × 1). Two weeks later, he develops sudden onset bilateral lower extremity weakness and numbness. MRI shows new T2 hyperintensity in the thoracolumbar cord extending beyond the radiation field. What is the most likely diagnosis?", "options": ["Radiation myelopathy", "Leptomeningeal carcinomatosis", "Paraneoplastic myelitis associated with anti-amphiphysin antibodies", "Spinal cord infarction from tumor embolus", "Subacute combined degeneration from B12 deficiency"], "answer": "C", "answer_index": 2, "explanation": "This presentation describes a paraneometric myelitis triggered by radiation-induced tumor cell death releasing antigens, not direct radiation toxicity (which occurs after longer latency and respects radiation fields). Prostate cancer is associated with anti-amphiphysin antibodies that can cause myelitis. Leptomeningeal disease would show enhancement on MRI. Radiation myelopathy typically presents 6-24 months post-treatment. Cord infarction would have acute dramatic onset rather than subacute progression.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: sudden onset bilateral lower extremity weakness/numbness 2 weeks after palliative radiotherapy (8 Gy × 1) to lumbar spine, with MRI showing new T2 hyperintensity in thoracolumbar cord extending beyond radiation field. The most likely diagnosis is radiation myelopathy (A), given the classic presentation of early-delayed radiation myelopathy (transient, reversible, within weeks to months, often with cord edema extending beyond field), especially after a single 8 Gy fraction for spine metastasis. The keyed answer (C, paraneoplastic myelitis) is improbable as a 'most likely' cause; paraneoplastic syndromes are rare, and anti-amphiphysin is more strongly associated with breast/small cell lung cancer, not prostate cancer. No internal contradiction or underspecification. Main medical accuracy issue: the rationale incorrectly dismisses radiation myelopathy based on an overly narrow latency (6-24 months) that ignores early-delayed forms. Minimal fix: Change key to A and adjust rationale to acknowledge early-delayed radiation myelopathy as the most common cause in this timeline.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: sudden onset bilateral lower extremity weakness/numbness 2 weeks after palliative radiotherapy (8 Gy × 1) to lumbar spine, with MRI showing new T2 hyperintensity in thoracolumbar cord extending beyond radiation field. The most likely diagnosis is radiation myelopathy (A), given the classic presentation of early-delayed radiation myelopathy (transient, reversible, within weeks to months, often with cord edema extending beyond field), especially after a single 8 Gy fraction for spine metastasis. The keyed answer (C, paraneoplastic myelitis) is improbable as a 'most likely' cause; paraneoplastic syndromes are rare, and anti-amphiphysin is more strongly associated with breast/small cell lung cancer, not prostate cancer. No internal contradiction or underspecification. Main medical accuracy issue: the rationale incorrectly dismisses radiation myelopathy based on an overly narrow latency (6-24 months) that ignores early-delayed forms. Minimal fix: Change key to A and adjust rationale to acknowledge early-delayed radiation myelopathy as the most common cause in this timeline.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-013", "question": "A 58-year-old man undergoes left lower lobectomy for stage IIA NSCLC. On postoperative day 2, he develops productive cough and low-grade fever. Chest tube output increases to 450 mL/day of serosanguinous fluid. Fluid analysis shows pH 7.25, glucose 45 mg/dL, LDH 485 U/L. What is the most appropriate management?", "options": ["Insertion of a second chest tube", "Immediate return to operating room for exploration", "Initiation of broad-spectrum antibiotics alone", "Video-assisted thoracoscopic drainage and pleural irrigation", "Observation with repeat chest radiograph in 24 hours"], "answer": "D", "answer_index": 3, "explanation": "The fluid characteristics (low pH, low glucose, elevated LDH) indicate an early empyema or complicated parapneumonic effusion. VATS allows direct visualization, breakdown of loculations, thorough irrigation, and precise tube placement. A second chest tube may not address localized infection. Reoperation is premature without attempted minimally invasive drainage. Antibiotics alone won't drain the infected space. Observation risks progression to fibrinopurulent stage.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Post-lobectomy day 2, increased chest tube output, fluid with low pH (7.25), low glucose (45 mg/dL), and elevated LDH (485 U/L) are classic for an early complicated parapneumonic effusion/empyema. Main logical issue: None; the findings uniquely point to a localized infected space requiring drainage. Main medical accuracy issue: None; the fluid analysis interpretation and management are consistent with standard thoracic surgery/IDSA guidelines. Minimal fix: None required for a valid item. The rationale correctly identifies VATS drainage and irrigation as the most appropriate step before considering reoperation.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Post-lobectomy day 2, increased chest tube output, fluid with low pH (7.25), low glucose (45 mg/dL), and elevated LDH (485 U/L) are classic for an early complicated parapneumonic effusion/empyema. Main logical issue: None; the findings uniquely point to a localized infected space requiring drainage. Main medical accuracy issue: None; the fluid analysis interpretation and management are consistent with standard thoracic surgery/IDSA guidelines. Minimal fix: None required for a valid item. The rationale correctly identifies VATS drainage and irrigation as the most appropriate step before considering reoperation.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-014", "question": "A 68-year-old woman with a history of thoracic endovascular aortic repair (TEVAR) for descending aortic aneurysm presents with hoarseness and dysphagia. Barium swallow shows external compression of the esophagus without mucosal abnormality. Which management strategy addresses the most likely etiology while minimizing procedural risk?", "options": ["Revision TEVAR with proximal extension", "Direct laryngoscopy with vocal cord medialization", "Esophageal stent placement", "CT angiography of the chest with 3D reconstruction", "Open surgical aneurysm repair via left thoracotomy"], "answer": "D", "answer_index": 3, "explanation": "Hoarseness suggests recurrent laryngeal nerve palsy, and dysphagia indicates mechanical compression-findings consistent with a newly enlarging aortic aneurysm at the TEVAR landing zone causing mass effect. CTA provides definitive evaluation of aneurysm size and relationship to adjacent structures. Endoscopy may show compression but cannot characterize the extracesophageal cause. Revision TEVAR or open repair would be premature without demonstrating aneurysm growth. Mere observation misses the opportunity for timely intervention if expansion is confirmed.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. The stem describes a patient with prior TEVAR presenting with hoarseness and dysphagia, with barium swallow showing external esophageal compression. The most likely etiology is a recurrent or enlarging aortic aneurysm causing mass effect. The keyed answer (D, CT angiography) is a diagnostic test, not a management strategy, which directly contradicts the stem's question: 'Which management strategy...?' This makes the item internally contradictory. A unique best management answer exists (likely A, revision TEVAR, if growth is confirmed), but the key points to a diagnostic step. Main logical issue: The keyed answer does not fulfill the question's requirement for a management strategy. Minimal fix: Change the stem to ask for the 'most appropriate next diagnostic step' or change the key to a management option (e.g., A) and adjust the rationale accordingly.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1032)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-015", "question": "A 47-year-old woman with situs inversus totalis presents with recurrent episodes of acute pancreatitis. MRCP shows pancreas divisum with Santorinicole in the dorsal duct. Previous minor papilla sphincterotomy provided only temporary relief. What is the most appropriate definitive management?", "options": ["Total pancreatectomy with islet autotransplantation", "Long-term pancreatic stent placement across the minor papilla", "Endoscopic ultrasound-guided gastroenterostomy creation", "Surgical dorsal duct jejunostomy (Puestow procedure)", "Repeat ERCP with extended sphincterotomy and stricture dilation"], "answer": "A", "answer_index": 0, "explanation": "In the setting of situs inversus with complex pancreatic duct anatomy (Santorinicole) and failed sphincterotomy, TP-IAT offers the only definitive solution for recurrent pancreatitis while preserving endocrine function. The anomalous anatomy makes standard drainage procedures (Puestow) technically challenging and less effective. Long-term stenting leads to ductal changes and strictures. EUS-guided drainage would not address the underlying drainage impairment from the Santorinicole.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The stem describes recurrent pancreatitis due to pancreas divisum with a Santorinicole (a cystic dilation of the dorsal duct) and failed minor papilla sphincterotomy. The keyed answer (A, total pancreatectomy with islet autotransplantation) is a drastic, last-resort option for severe, debilitating chronic pancreatitis, not typically the next step after a single failed sphincterotomy for an anatomic variant. The most appropriate definitive management in this scenario, per standard gastroenterology/surgical guidelines, is a surgical drainage procedure (D, Puestow procedure or its modifications like lateral pancreaticojejunostomy), which is the established treatment for recurrent pancreatitis due to ductal dilation from obstruction. The stem lacks justification for leaping to total pancreatectomy. Medical accuracy is mostly sound, but the key is not the best answer. Minimal fix: Change the key to D (Surgical dorsal duct jejunostomy).\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1108)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-016", "question": "A 52-year-old man with alcohol-related cirrhosis presents with acute upper GI bleeding. During emergent endoscopy, active spurting is seen from a large duodenal ulcer in the posterior bulb. After epinephrine injection and placement of two through-the-scope clips, bleeding continues. The following day, he develops fever and severe abdominal pain. CT shows retroperitoneal air and fluid tracking along the right psoas muscle. What is the most appropriate management?", "options": ["Angiographic embolization of the gastroduodenal artery", "Emergency laparotomy with duodenal diversion", "Percutaneous drainage of the retroperitoneal collection", "Repeat endoscopy with over-the-scope clip placement", "IV antibiotics and serial abdominal exams"], "answer": "B", "answer_index": 1, "explanation": "This scenario describes a posterior duodenal ulcer perforation into the retroperitoneum following endoscopic intervention. Given the ongoing bleeding and established contamination, definitive surgical management with duodenal diversion (e.g., Graham patch closure with gastrodujunostomy) is required. Angioembolization would address bleeding but not the perforation. Percutaneous drainage cannot control the duodenal leak. Repeat endoscopy is contraindicated with known perforation. Antibiotics alone would lead to uncontrolled sepsis.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: acute upper GI bleeding from a posterior duodenal ulcer with failed endoscopic hemostasis, followed by fever, severe pain, and CT findings of retroperitoneal air/fluid tracking. This indicates a perforated posterior duodenal ulcer with ongoing bleeding. The most appropriate management is angiographic embolization (A) to control the bleeding, as it is minimally invasive and effective for posterior ulcers with vascular erosion, followed by percutaneous drainage (C) for the established retroperitoneal collection. Emergency laparotomy (B) is a high-risk option in a cirrhotic patient and is not the first-line for a contained retroperitoneal perforation with bleeding. The item is medically accurate but miskeyed; the best answer is A, not B. Minimal fix: Change the key to A.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: acute upper GI bleeding from a posterior duodenal ulcer with failed endoscopic hemostasis, followed by fever, severe pain, and CT findings of retroperitoneal air/fluid tracking. This indicates a perforated posterior duodenal ulcer with ongoing bleeding. The most appropriate management is angiographic embolization (A) to control the bleeding, as it is minimally invasive and effective for posterior ulcers with vascular erosion, followed by percutaneous drainage (C) for the established retroperitoneal collection. Emergency laparotomy (B) is a high-risk option in a cirrhotic patient and is not the first-line for a contained retroperitoneal perforation with bleeding. The item is medically accurate but miskeyed; the best answer is A, not B. Minimal fix: Change the key to A.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-017", "question": "A 35-year-old woman with tuberous sclerosis complex develops rapidly progressive renal insufficiency. Imaging shows massively enlarged kidneys with innumerable angiomyolipomas, the largest measuring 8 cm. What is the most appropriate intervention to preserve renal function?", "options": ["Selective arterial embolization of the dominant tumors", "Initiation of everolimus therapy", "Bilateral nephrectomy with dialysis initiation", "Cryoablation of the largest angiomyolipomas", "Radical nephrectomy of the more affected kidney"], "answer": "B", "answer_index": 1, "explanation": "In TSC with diffuse angiomyolipomatosis causing renal failure, everolimus (an mTOR inhibitor) is first-line therapy as it targets the underlying pathophysiology, can reduce tumor size by over 50%, and preserves renal function better than procedural interventions. Embolization or ablation would be impractical for innumerable tumors and could accelerate renal decline. Nephrectomy should be avoided unless absolutely necessary for hemorrhage control. Everolimus addresses the systemic nature of TSC renal involvement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: tuberous sclerosis complex, rapidly progressive renal insufficiency, massively enlarged kidneys with innumerable angiomyolipomas. The clinical problem is identifying the systemic, disease-modifying therapy for TSC-related angiomyolipomatosis causing renal decline. Everolimus (mTOR inhibitor) is the established first-line medical therapy to reduce tumor burden and preserve renal function in this diffuse, bilateral setting, per current guidelines. Procedural options (embolization, ablation, nephrectomy) are impractical for innumerable tumors and are reserved for specific complications like hemorrhage. The item is logically valid and medically accurate. Minimal fix: None required; the item is well-constructed.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 904)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-018", "question": "A 6-month-old boy presents with recurrent sinopulmonary infections, failure to thrive, and absent lymph nodes on examination. Flow cytometry shows profoundly decreased T cells with normal B cell numbers. Mitogen proliferation assays show no response. Genetic testing reveals a missense mutation in the ORAI1 gene. What specific immunologic defect is present?", "options": ["Defective thymic epithelial development", "Impaired VDJ recombination in T cell receptors", "Absence of stores operated calcium entry", "Mutation in the ζ-chain-associated protein kinase", "Adenosine deaminase deficiency with metabolic toxicity"], "answer": "C", "answer_index": 2, "explanation": "ORAI1 encodes a calcium release-activated calcium channel essential for store-operated calcium entry (SOCE), which is critical for T cell activation, cytokine production, and immune function. Without SOCE, T cells cannot properly activate despite normal development, explaining the severe combined immunodeficiency presentation with normal lymphocyte numbers but functional impairment. This is distinct from recombination defects (RAG, Artemis) or metabolic deficiencies (ADA). The ORAI1 mutation specifically disrupts calcium signaling after T cell receptor engagement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The stem clearly describes a severe combined immunodeficiency (SCID) phenotype with recurrent infections, failure to thrive, absent lymph nodes, profoundly decreased T cells, normal B cells, and absent mitogen response. The specific genetic finding of an ORAI1 missense mutation directly points to a defect in store-operated calcium entry (SOCE), which is essential for T cell activation. This makes option C uniquely correct. The other options are incorrect: A (thymic defect) is not indicated; B (VDJ recombination) would affect both T and B cells; D (ZAP-70 mutation) causes a different T cell signaling block; E (ADA deficiency) causes lymphopenia. No logical contradictions or missing details exist. The medical content is accurate and aligns with known immunology. Minimal fix: None required; the item is already clear and valid.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1007)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-019", "question": "A 30-year-old missionary presents with a slowly enlarging scalp lesion after returning from Bolivia. biopsy demonstrates lobulated granulomatous inflammation with rare 5-7 μm budding yeast. Culture on brain-heart infusion agar at 25°C shows cream-colored colonies that convert to yeast form at 37°C. What is the most appropriate antifungal therapy?", "options": ["Itraconazole for 6-12 months", "Amphotericin B lipid complex followed by itraconazole", "Voriconazole indefinitely", "Posaconazole with therapeutic drug monitoring", "Fluconazole for 3-6 months"], "answer": "A", "answer_index": 0, "explanation": "The presentation describes cutaneous granulomas caused by Paracoccidioides brasiliensis, endemic to Latin America. Itraconazole is first-line for non-severe disease, with 6-12 months treatment typically achieving cure. Amphotericin B is reserved for severe disseminated disease. Voriconazole has variable activity against Paracoccidioides. Fluconazole is less effective due to higher relapse rates. The dimorphic growth pattern and geographic history are classic for this infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: slowly enlarging scalp lesion in a patient returning from Bolivia (endemic for Paracoccidioides), biopsy showing granulomatous inflammation with small budding yeast, and culture showing dimorphism (mold at 25°C, yeast at 37°C). This classic presentation and microbiology uniquely point to paracoccidioidomycosis. The keyed answer (A, itraconazole for 6-12 months) is the guideline-recommended first-line therapy for localized, non-severe disease. Alternatives are incorrect: amphotericin B (B) is for severe/disseminated disease, voriconazole (C) is not first-line, posaconazole (D) is an alternative but not the standard first choice, and fluconazole (E) is less effective with higher relapse. No logical contradictions or missing details. Medical accuracy is sound. Minimal fix: none required; item is clear and accurate.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 995)"}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-020", "question": "A 42-year-old woman with HIV (CD4 180 cells/μL, viral load undetectable on ART) presents with 2 weeks of progressive neurological decline. MRI shows multiple ring-enhancing lesions with minimal edema. CSF PCR is negative for JC virus, toxoplasma, and CMV. Brain biopsy reveals necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions. What is the most appropriate treatment?", "options": ["High-dose ganciclovir", "Intravenous foscarnet", "Artemisinin combination therapy", "Pyrimethamine plus sulfadiazine", "Cidofovir with probenecid"], "answer": "B", "answer_index": 1, "explanation": "The histopathological findings are characteristic of cytomegalovirus encephalitis, which can present with atypical MRI findings in immunocompromised hosts. Foscarnet is preferred over ganciclovir in this scenario because CMV encephalitis in HIV patients often occurs despite undetectable plasma viral loads, suggesting possible ganciclovir resistance or poor CNS penetration. Foscarnet has different mechanisms of action and better CNS penetration. The negative CSF PCR does not rule out CMV encephalitis due to low viral loads. Arteminsinin and anti-toxoplasma therapies would not address CMV.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: HIV patient with CD4 180, progressive neurological decline, MRI ring-enhancing lesions, negative CSF PCR for common pathogens, biopsy showing necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions. The histopathologic description is classic for progressive multifocal leukoencephalopathy (PML) caused by JC virus, not CMV. CMV inclusions are typically intranuclear and intracytoplasmic, but 'bizarre astrocytes' are a hallmark of JC virus infection. The negative CSF PCR does not rule out JC virus CNS disease, as sensitivity is not 100%, especially with low viral load. A unique best answer exists but is not the keyed option. Main logical issue: The key (foscarnet for CMV) is incorrect given the pathologic findings point to JC virus, for which there is no established antiviral therapy (best answer would be optimization of ART and possibly mirtazapine or other experimental therapies, none listed). The item is medically inaccurate in its core association. Minimal fix: Change the biopsy findings to describe cytomegalic cells with intranuclear and intracytoplasmic inclusions (owl's eye) to support CMV, or change the key to reflect that no effective antiviral therapy exists for JC virus PML and the best answer among options is supportive care/ART optimization (not listed).\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: HIV patient with CD4 180, progressive neurological decline, MRI ring-enhancing lesions, negative CSF PCR for common pathogens, biopsy showing necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions. The histopathologic description is classic for progressive multifocal leukoencephalopathy (PML) caused by JC virus, not CMV. CMV inclusions are typically intranuclear and intracytoplasmic, but 'bizarre astrocytes' are a hallmark of JC virus infection. The negative CSF PCR does not rule out JC virus CNS disease, as sensitivity is not 100%, especially with low viral load. A unique best answer exists but is not the keyed option. Main logical issue: The key (foscarnet for CMV) is incorrect given the pathologic findings point to JC virus, for which there is no established antiviral therapy (best answer would be optimization of ART and possibly mirtazapine or other experimental therapies, none listed). The item is medically inaccurate in its core association. Minimal fix: Change the biopsy findings to describe cytomegalic cells with intranuclear and intracytoplasmic inclusions (owl's eye) to support CMV, or change the key to reflect that no effective antiviral therapy exists for JC virus PML and the best answer among options is supportive care/ART optimization (not listed).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}]